Published in Clin Exp Immunol on January 01, 1985
A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44
In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cell Res (1977) 9.38
Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med (1981) 5.76
Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. J Immunol (1983) 4.94
Direct evidence for the presence of histidine in the active center of chymotrypsin. Biochemistry (1963) 4.26
The carbohydrate-binding specificity of pea and lentil lectins. Fucose is an important determinant. J Biol Chem (1981) 2.67
Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. II. Studies of B73.1 antibody-antigen interaction on the lymphocyte membrane. J Immunol (1983) 2.37
The structural basis of the different affinities of two types of acidic N-glycosidic glycopeptides for concanavalin A--sepharose. FEBS Lett (1976) 1.84
Characterization of the cytolytic reaction mechanism of the human natural killer (NK) lymphocyte: resolution into binding, programming, and killer cell-independent steps. J Immunol (1982) 1.51
The mechanism of cell-mediated cytotoxicity. I. Killing by murine cytotoxic T lymphocytes requires cell surface thiols and activated proteases. J Immunol (1980) 1.45
Inhibition of human natural cytotoxicity by macromolecular antiproteases. J Immunol (1981) 1.27
T lymphocyte-mediated cytolysis. I. A common mechanism for target recognition in specific and lectin-dependent cytolysis. J Immunol (1981) 1.14
The site of action of N-alpha-tosyl-L-lysyl-chloromethyl-ketone (TLCK) on cloned cytotoxic T lymphocytes. J Immunol (1983) 1.11
Definition of a "trigger" stage in the NK cytolytic reaction sequence by a monoclonal antibody to the glycoprotein T-200. J Immunol (1983) 1.11
Natural cytotoxic reactivity of human lymphocyte subpopulations. Immunology (1979) 1.07
Antibody-dependent cell-mediated cytotoxicity in humans. III. Effect of protease inhibitors and substrates. J Immunol (1976) 1.07
The mechanism of cell-mediated cytotoxicity. III. Protease-specific inhibitors preferentially block later events in cytotoxic T lymphocyte-mediated lysis than do inhibitors of methylation or thiol-reactive agents. Cell Immunol (1983) 0.99
Induction of NKCF-like activity in mixed lymphocyte-tumor cell culture: direct involvement of mycoplasma infection of tumor cells. J Immunol (1984) 0.97
Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit. J Immunol (1983) 0.87
Production of plasminogen activator by human natural killer cells. Large granular lymphocytes. J Exp Med (1984) 0.86
In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432. J Natl Cancer Inst (1982) 0.85
Lectin-binding characteristics of human natural killer cells. Immunology (1982) 0.84
Characterization of mouse natural killer cell activating factor (NKAF) induced by OK-432: evidence for interferon- and interleukin 2-independent NK cell activation. Br J Cancer (1984) 0.77
Studies on the mechanism of the human natural killer cell lethal hit: evidence for transfer of protease-sensitive structures requisite for target cell lysis. J Immunol (1983) 0.77
Flow cytometric analysis of lectin binding to human peripheral blood lymphocytes. Biochem J (1982) 0.77
Observational study of effect of patient centredness and positive approach on outcomes of general practice consultations. BMJ (2001) 8.76
Evidence for the effects of HIV antibody counseling and testing on risk behaviors. JAMA (1991) 7.35
Performance indicators for primary care groups: an evidence based approach. BMJ (1998) 6.97
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature (2000) 6.54
Preferences of patients for patient centred approach to consultation in primary care: observational study. BMJ (2001) 6.17
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature (2000) 5.86
The chorio-allantoic membrane of the developing chick as a medium for the cultivation and histopathologic study of pathogenic fungi. Am J Pathol (1941) 4.64
23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet (2000) 4.23
Gain of function mutations in p53. Nat Genet (1993) 4.19
Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ (2001) 4.18
Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci U S A (1997) 4.10
The Chorioallantoic Membrane of Chick Embryos and Its Response to Inoculation with Some Mycobacteria. Am J Pathol (1942) 4.02
Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg (1996) 3.76
Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics (2000) 3.48
TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity (2001) 3.43
The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol Cell Biol (1986) 3.36
A study of clients returning for counseling after HIV testing: implications for improving rates of return. Public Health Rep (1993) 3.01
Multiple adenovirus serotypes use alpha v integrins for infection. J Virol (1994) 2.86
Relationship between trauma center volume and outcomes. JAMA (2001) 2.56
Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med (2001) 2.51
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer. J Clin Oncol (2002) 2.46
CAISSON DISEASE WITH SPECIAL REFERENCE TO THE BONES AND JOINTS: REPORT OF TWO CASES. Ann Surg (1940) 2.44
Dipsticks and diagnostic algorithms in urinary tract infection: development and validation, randomised trial, economic analysis, observational cohort and qualitative study. Health Technol Assess (2009) 2.36
Randomised controlled trial of self management leaflets and booklets for minor illness provided by post. BMJ (2001) 2.35
GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron (1998) 2.34
Overnight calls in primary care: randomised controlled trial of management using nurse telephone consultation. BMJ (1999) 2.32
Tuberculosis among foreign-born persons in the United States, 1993-1998. JAMA (2000) 2.31
Validation study of a diary for use in acute lower respiratory tract infection. Fam Pract (2001) 2.24
Importance of lead selection in QT interval measurement. Am J Cardiol (1988) 2.23
Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group. Lancet (1996) 2.20
Clinical governance in primary care groups: the feasibility of deriving evidence-based performance indicators. Qual Health Care (2000) 2.16
Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell (1994) 2.15
Phosphorylation and activation of cAMP-dependent protein kinase by phosphoinositide-dependent protein kinase. Proc Natl Acad Sci U S A (1998) 2.09
Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker. Br J Cancer (1984) 2.05
A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer. Ann Oncol (2007) 2.03
Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis. Circ Res (2001) 2.00
Cost analysis of nurse telephone consultation in out of hours primary care: evidence from a randomised controlled trial. BMJ (2000) 1.99
Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J Exp Med (1996) 1.93
Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med (1977) 1.85
POLYAMINES, RNA SYNTHESIS, AND STREPTOMYCIN LETHALITY IN A RELAXED MUTANT OF E. coli STRAIN 15 TAU. Proc Natl Acad Sci U S A (1967) 1.82
Demonstration of cell-surface antigens on chemically induced tumors. Ann N Y Acad Sci (1971) 1.78
Psychosocial, lifestyle, and health status variables in predicting high attendance among adults. Br J Gen Pract (2001) 1.76
Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor. J Biol Chem (2001) 1.73
THE CHORIO-ALLANTOIC MEMBRANE OF THE DEVELOPING CHICK AS A MEDIUM FOR THE CULTIVATION AND HISTOPATHOLOGIC STUDY OF PATHOGENIC FUNGI. Science (1939) 1.71
Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer (2009) 1.69
Centers for Disease Control. Enteroviral disease in the United States, 1970-1979. J Infect Dis (1982) 1.69
Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells. Br J Pharmacol (2010) 1.65
Nucleotide sequence of a chromosomal mercury resistance determinant from a Bacillus sp. with broad-spectrum mercury resistance. J Bacteriol (1989) 1.64
Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships. Toxicol Appl Pharmacol (1997) 1.61
Stage I testicular seminoma: results of adjuvant irradiation and surveillance. J Clin Oncol (1995) 1.61
Reduced importation of tuberculosis after the implementation of an enhanced pre-immigration screening protocol. Int J Tuberc Lung Dis (2011) 1.60
Doses to critical organs following radiotherapy and concomitant imaging of the larynx and breast. Br J Radiol (2007) 1.58
Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat Genet (1997) 1.55
Blood-brain barrier impairment in Alzheimer disease: stability and functional significance. Neurology (2007) 1.53
Hematopoietic defects in mice lacking the sialomucin CD34. Blood (1996) 1.46
Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants. J Pediatr (2001) 1.44
The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006. Ann Oncol (2007) 1.44
Battling the biomedical information explosion: a plan for implementing a quality filtered database. Med Ref Serv Q (1989) 1.44
Management of stage II seminoma. J Clin Oncol (1998) 1.43
Isolation and structure elucidation of Chlorofusin, a novel p53-MDM2 antagonist from a Fusarium sp. J Am Chem Soc (2001) 1.43
Local toxicity with subcutaneous methadone. Experience of two centers. Pain (1991) 1.43
Evaluation of a proposed method for representing drug terminology. Proc AMIA Symp (1999) 1.42
Tuberculosis contact investigations: outcomes in selected areas of the United States, 1999. Int J Tuberc Lung Dis (2003) 1.41
Distribution of histocompatibility and leucocyte differentiation antigens in normal human colon and in benign and malignant colonic neoplasms. Br J Cancer (1984) 1.40
Plasma membrane water permeability of cultured cells and epithelia measured by light microscopy with spatial filtering. J Gen Physiol (1997) 1.39
Health and the World Trade Organization. N Z Med J (2000) 1.39
Human tumor-infiltrating lymphocytes: a marker of host response. Semin Hematol (1985) 1.38
Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study. Gastroenterology (1981) 1.38
Specific and non-specific lymphocyte cytotoxicity in colon carcinoma. Br J Cancer (1981) 1.31
The popliteal artery and its branches: embryologic basis of normal and variant anatomy. AJR Am J Roentgenol (1988) 1.31
Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease. Br J Cancer (1984) 1.31
Structuring HIV prevention service delivery systems on the basis of social science theory. J Community Health (1992) 1.29
Core RNA polymerase and promoter DNA interactions of purified domains of sigma N: bipartite functions. J Mol Biol (1995) 1.29
No association between hepatitis C and B-cell lymphoma. Hepatology (1999) 1.28
Epidural butorphanol or morphine for the relief of post-cesarean section pain: ventilatory responses to carbon dioxide. Anesth Analg (1987) 1.28
A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma. Cancer (1996) 1.27
Increasing empathy among medical students. Med Educ (1989) 1.27
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008. Ann Oncol (2009) 1.26
HIV infection and AIDS in England and Wales: general practitioners' workload and contact with patients. Br J Gen Pract (1990) 1.25
Natural cytotoxicity in humans: susceptibility of freshly isolatd tumor cells to lysis. J Natl Cancer Inst (1980) 1.24
Reactions to the use of evidence-based performance indicators in primary care: a qualitative study. Qual Health Care (2000) 1.24
The load that maximizes the average mechanical power output during jump squats in power-trained athletes. J Strength Cond Res (2001) 1.24
Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study. Ann Oncol (2005) 1.23
Diarrheal illness among infants and toddlers in day care centers. I. Epidemiology and pathogens. J Pediatr (1985) 1.23
Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours. Int J Cancer (1979) 1.22
Isolation of membrane-associated tumour-specific antigen from an aminoazo-dye-induced rat hepatoma. Int J Cancer (1969) 1.21
The role of performance indicators in changing the autonomy of the general practice profession in the UK. Soc Sci Med (2003) 1.18
Expression of Streptococcus mutans fimA is iron-responsive and regulated by a DtxR homologue. Microbiology (2001) 1.18
Use of inflammatory markers to guide cancer treatment. Clin Pharmacol Ther (2011) 1.18
The effect of adherent and phagocytic cells on human lymphocyte PHA responsiveness. Clin Exp Immunol (1977) 1.18
Managing hypertension in the southeastern United States: applying the guidelines from the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Am J Med Sci (1999) 1.17
Tumour inhibition mediated by BCG in immunosuppressed rats. Int J Cancer (1975) 1.17
Lamprey fibrinogen gamma chain: cloning, cDNA sequencing, and general characterization. Biochemistry (1985) 1.16
An improved apparatus for the optical recording of contraction of single heart cells. Pflugers Arch (1988) 1.16
Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and up-regulates the adenylosuccinate synthetase 1 gene. J Biol Chem (2000) 1.15
Food motivated behavior of melanocortin-4 receptor knockout mice under a progressive ratio schedule. Peptides (2006) 1.15